🦠Eric Mauser
About 🦠Eric Mauser
Eric Mauser serves as the Associate Director of Gene Based Assays at Sana Biotechnology, Inc., where he specializes in developing molecular assays and has significant experience in viral vector technology. He holds a Master's degree in Biotechnology and has worked in various roles in the biotechnology sector, contributing to FDA-approved therapies and leading analytical strategies.
Work at Sana Biotechnology
Eric Mauser serves as the Associate Director of Gene Based Assays at Sana Biotechnology, Inc. since 2022. In this role, he leads the vector analytical strategy for a significant pre-clinical program. His responsibilities include developing novel molecular assays to characterize cellular drug products and vectors, which are essential for advancing the company's research initiatives.
Education and Expertise
Eric Mauser obtained a Master of Science in Biotechnology from Indiana University Bloomington, where he studied from 2013 to 2015. He also earned a Certificate in the Business of Life Sciences from the Kelley School of Business at Indiana University, completing this program from 2012 to 2013. His educational background equips him with a strong foundation in both scientific and business aspects of biotechnology.
Background
Eric Mauser has a diverse professional background in the biotechnology sector. He began his career as an Associate Scientist at Celgene from 2018 to 2019, followed by a role as a Senior Research Associate at Juno Therapeutics, Inc. from 2015 to 2018. He later worked at Bristol Myers Squibb as an Associate Scientist and then as a Scientist/Manager from 2019 to 2022, gaining extensive experience in laboratory management and technical consulting.
Achievements
During his tenure at Juno Therapeutics, Eric Mauser contributed to the data and Biologics License Application (BLA) authoring for Breyanzi, an FDA-approved commercial cell therapy. His work involved collaborating with contract manufacturing organizations (CMOs) to develop and manufacture large-scale GMP-grade viral vectors, showcasing his expertise in viral vector technology and manufacturing.
Skills and Techniques
Eric Mauser is skilled in various molecular biology techniques, including quantitative PCR (qPCR), endpoint PCR, and quantitative reverse transcription PCR (qRT-PCR). He has experience in designing assays and enhancing existing ones through quantitative analysis. Additionally, he is proficient in several software tools, such as MS Office, BLAST, MACVector, and PyMOL, which support his research and analytical tasks.